Abstract 4369552: Role of the Polycystin-1 C-Terminus in Regulating Cardiomyocyte Protein Synthesis

M Matthew Fiedler (Houston Methodist, Houston, Texas, United States) E Ernesto Reyes Sanchez (Houston Methodist, Houston, Texas, United States) A Alejandra Vasquez Limeta (Houston Methodist, Houston, Texas, United States) L Leah Carter (Houston Methodist, Houston, Texas, United States) F Francisco Altamirano (Houston Methodist, Houston, Texas, United States)

Abstract

Introduction: Polycystin-1 (PC1) is a large transmembrane protein expressed across the body. While PC1 mutations are responsible for ~85% of autosomal dominant polycystic kidney disease (ADPKD) cases, PC1 is increasingly recognized as a key regulator of hypertrophic growth in cardiomyocytes following mechanical stress. The exact role of PC1 in human cardiomyocyte hypertrophy remains unclear. Goal: We utilized induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) to investigate the role of PC1 in regulating molecular mechanisms underlying hypertrophic growth in human cells. Methods: iPSC-CMs were differentiated through temporal modulation of Wnt pathway signaling. Cyclic stretch was applied to iPSC-CM monolayers using IonOptix C-Stretch. Gene expression was analyzed via bulk RNA-seq. Additionally, LacZ and the C-terminus of PC1 (PC1-CT) were overexpressed using adenovirus. Results: Endogenously expressed PC1-CT localizes to the plasma membrane and within sarcomere structures in adult mouse ventricular cardiomyocytes and iPSC-CMs. Silencing of PC1 blunted the early hypertrophic response to cyclic stretch in iPSC-CMs. To determine whether the PC1-CT mediates hypertrophic remodeling, we overexpressed this fragment using an adenovirus. RNA-sequencing revealed that PC1-CT overexpression in iPSC-CMs increased the expression of protein synthesis-associated genes, while hypertrophy-associated genes remained unchanged. Similarly, unchanged levels were observed for the hypertrophic markers NPPA and NPPB, which were further confirmed via qPCR. Western blotting indicated that PC1-CT overexpression activates Akt and partially mTOR, evidenced by increases in p-S6K1 and p-S6, but not p-4EPB1. Other pathways, including p38, JNK, Creb, or insulin-receptor/insulin-receptor-like signaling, were unaffected. Additionally, the PI3K inhibitor LY294002 blunted Akt and S6 phosphorylation induced by PC1-CT overexpression. Conclusions: Our data indicate that PC1 regulates stretch-induced hypertrophic remodeling in iPSC-CMs. PC1-CT overexpression activates Akt/mTOR/S6K1/S6, impacting gene expression of protein synthesis pathways. Considering the lack of classical hypertrophic gene activation and the unique localization exhibited, PC1-CT may regulate a local sub-pool of Akt relegated to or near sarcomeric structures. Additionally, our results suggest that other protein domains within PC1 are required to promote hypertrophic remodeling in cardiomyocytes.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (5)

M

Matthew Fiedler

Houston Methodist, Houston, Texas, United States

E

Ernesto Reyes Sanchez

Houston Methodist, Houston, Texas, United States

A

Alejandra Vasquez Limeta

Houston Methodist, Houston, Texas, United States

L

Leah Carter

Houston Methodist, Houston, Texas, United States

F

Francisco Altamirano

Houston Methodist, Houston, Texas, United States